PRKAA1 and glioma: On one hand, some studies describe that glioma cells showed AMPK-dependent effects, such as decreased proliferation, a block in G0/G1 cell cycle progression and induction of cell death in U87 cell line, that were supported by an AMPK inhibitor, Compound C or AICAR.